ARTICLE | Clinical News
Ninlaro ixazomib regulatory update
December 7, 2015 8:00 AM UTC
FDA approved an NDA from Takeda for Ninlaro ixazomib to treat multiple myeloma (MM) in combination with Revlimid lenalidomide and dexamethasone in patients who have received >=1 prior therapy. The PD...